Globe Newswire
TORONTO, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced that the Company will hold an Investor Day on March 2, 2026, at 11:00 am Eastern Time (“ET”), to be followed by a Q&A discussion. Details of the event are provided below. The presentation will also be webcast and available on the Company’s website at www.discoverysilver.com.
Details
Date: Monday, March 2, 2026, Time: 11:00 am... (continue reading...)
Maranello (Italy), February 9 2026 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that the Company has purchased, under the Euro 250 million share buyback program announced on December 16, 2025, as the first tranche of the multi-year share buyback program of approximately Euro 3.5 billion expected to be executed by 2030 in line with the disclosure made during the 2025 Capital Markets Day (the “First Tranche”), the additional common shares -... (continue reading...)
Vancouver, BC, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Deep Sea Minerals Corp. (CSE: SEAS) (OTCPK: DSEAF) (FSE: X45) ("Deep Sea" or the "Company") a subsea mineral exploration and development company focused on advancing critical mineral opportunities from the deep ocean, is pleased to announce, further to its news release dated January 21, 2026, that the Company has closed the previously announced non-brokered private placement of common shares in the capital of the... (continue reading...)
Grants Awarded to Two Patient Advocacy Organizations to Support Communications and Community Outreach
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the recipients of its eighth annual Communications Grant Program, intended to support increased communications, awareness building and community engagement.
Two grants were awarded this year to patient advocacy organizations serving the... (continue reading...)
Accretive Transaction with Combined Companies’ Pro-Forma Revenue in Excess of $70.00 Million and EBITDA(1) in Excess of $15.75 Million (TTM Sept 30, 2025)
MISSISSAUGA, Ontario, Feb. 09, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture (TSXV): RX) announced today that it has entered into a Share Purchase Agreement (“SPA”) dated February 8, 2026 to acquire Oral Science Inc. (“Oral Science”), a privately-owned Canadian distributor of specialized... (continue reading...)
More Globe Newswire
View Older Stories-
FG Nexus Announces 1-for-5 Reverse Stock Split
-
Abaxx Exchange Partners with ipushpull to Deliver Real-Time Market Data Directly into Microsoft Excel
-
Sleep experts urge adoption of permanent standard time to protect public health as Americans prepare to ‘spring forward’
-
Anavex Life Sciences Reports Fiscal 2026 First Quarter Financial Results and Provides Business Update
-
Context Therapeutics to Participate in Upcoming Investor Conferences
-
Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease
-
Jeffs’ Brands: KeepZone AI Enters Into Anti-Submarine and Underwater Security Systems with Strategic Agreement
-
WISDOMTREE NATURAL GAS 3x DAILY LEVERAGED SECURITIES NOTICE OF ADJOURNMENT OF MEETING
-
Novo Nordisk A/S - share repurchase programme
-
Digitally Engineered Precision: Professor John A. Sorensen Unveils Complex Full-Arch Implant Case Featuring Besmile’s Advanced Workflow
-
BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360° Conference
-
Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology
-
Kraig Biocraft Laboratories Poised for Explosive Spider Silk Production Growth
-
Outdoor Holding Company Reports Continued Profitability In Third Quarter Fiscal 2026
-
Zenas BioPharma Announces Late-Breaking Platform Presentation of Results from Phase 2 MoonStone Trial of Obexelimab in Relapsing Multiple Sclerosis at ACTRIMS Forum 2026
-
Form 8.3 - Picton Property Income Limited
-
Vitalist and MicroEJ Partner with BENIO to Launch First VitalOS™ Powered Smartwatch in Asia
-
Ocugen Appoints Rita Johnson-Greene to Chief Financial Officer
-
Form 8.3 - Bluefield Solar Income Fund Ltd
-
Maxim Power Corp. enters into a Gas Turbine and Generator Reservation Agreement and provides Prairie Lights Power Project Update
-
Itafos Files Technical Report for Updated Preliminary Economic Assessment for the Arraias Phosphate Project
-
Inotiv Reports First Quarter Financial Results for Fiscal 2026 and Provides Business Update
-
ValOre Approves Phase 2 of Metallurgical Testwork for Pedra Branca PGE project in Brazil: Program Underway in Partnership with the University of Cape Town Department of Chemical Engineering
-
Freehand Debuts as New Company with Dedicated AI Teams for Supply Chain Spend Management
-
Emerita Intersects 9.2m Grading 1.4% Copper, 0.4% Lead, 1.3% Zinc, 0.41 g/t Gold and 21.48 g/t Silver at El Cura
-
Westhaven Lists on the OTCQB Venture Market
-
Media Advisory: Wear Red Canada highlights heart disease crisis facing Canadian women
-
Volatus Secures Drone Training Contract with NATO Defence Partner
-
Ashland agrimer™ eco-coat polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations including for sale in the
-
SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy
-
Inspira Secures Vendor Approval from $12 Billion Revenue HMO (World’s 2nd Largest), Enabling Immediate ART100 Deployment
-
Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy
-
Astera Labs Expands Global Footprint with New Israel Design Center to Support Growing Demand for AI Connectivity Solutions
-
Talisker Intersects 52.2 g/t Au over 0.55 metres, within 19.15 g/t over 1.60 metres, from the 2025 Bralorne Gold Project Resource Conversion Program
-
Osisko Development Awards Project and Construction Management Services Contract for the Development of the Cariboo Gold Project
-
Oruka Therapeutics to Participate in Multiple Upcoming Conferences
-
NervGen Pharma Appoints Adam Rogers as Chief Executive Officer to Continue Leading the Company’s Growth and Execution of Its Mission in Spinal Cord Injury
-
First Intervention Shown to Lower Alzheimer’s and Dementia Incidence
-
GXO Announces Formation of Defense Advisory Board
-
Ashland agrimer™ eco-coat polymer seed coating from the Transformed Vegetable Oils (TVO) platform receives approval for all food and non-food uses in pesticide formulations including for sale in the
-
Hain Celestial Reports Fiscal Second Quarter 2026 Financial Results
-
Sportradar to Power NBA Fan Experiences Across NBC Sports Regional Sports Networks through Advanced Data and Enhanced Visual Storytelling
-
Swvl Secures a New Up to $1.5 Million Multi-Year Contract in Saudi Arabia, Expanding Its Healthcare Mobility Footprint Across the GCC
-
STUDY BY RAMSEY SOLUTIONS FINDS AMERICANS PREFER FINANCIAL STABILITY OVER EXCITEMENT IN A PARTNER
-
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
-
SparingVision Successfully Completes PRODYGY Trial Patient Dosing with SPVN06, its Novel Neuroprotective Gene Therapy
-
Schouw & Co. share buy-back programme, week 6 2026
-
Prospect Enhanced Yield Fund, a Debt-Focused Structured Credit Interval Fund, Announces 10.6% Net Annualized 3-Month Total Return and 9.0% Cash Dividend Yield (on Net Asset Value) on Fully Deployed An
-
Novo Nordisk takes legal action against Hims & Hers to protect patients from unsafe, knock-off Wegovy® and Ozempic®
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
